Genetically Predicted Leucine Level Mediates Association Between CD4/CD8br T Lymphocytes and Insomnia
- PMID: 39841266
- PMCID: PMC11754360
- DOI: 10.1007/s10571-025-01533-5
Genetically Predicted Leucine Level Mediates Association Between CD4/CD8br T Lymphocytes and Insomnia
Abstract
Immune and metabolic factors play an important role in the onset and development of insomnia. This study aimed to investigate the causal relationship between insomnia and immune cells and metabolites. Data for 731 immune cell phenotypes, 1400 metabolites, and insomnia in this study were obtained from the GWAS open-access database. Two-way Mendelian randomization was used to (1) detect the causal relationship between immune cells and insomnia and (2) identify potential mediating metabolites. Mendelian randomization analysis identified eight immune cell phenotypes with a causal relationship to insomnia, and two immune cell phenotypes were protective factors for insomnia, namely CD8br %T cells and CD80 on CD62L + myeloid dendritic cells. The other six immune cell phenotypes were risk factors for insomnia, i.e., CD4/CD8br, CD16-CD56 on NKT, CCR2 on myeloid dendritic cells, CD40 on monocytes, CD38 on CD3-CD19-, and CD25 on CD45RA + CD4 not Treg. Further Mendelian randomization revealed 11 metabolites that were causally related to insomnia. Five metabolites were protective factors for insomnia, i.e., 3-hydroxy-3-methylglutarate, cholate, dodecanedioate, N-formylmethionine, and x-26054. Six metabolites were risk factors for insomnia, 3-amino-2-piperidone, 6-oxopiperdine-2-carboxylate, caffeine to theophylline ratio, leucine, maltose, and x-24736. In addition, our analysis showed that leucine mediated the association between CD4/CD8br and insomnia. From genetic information, we confirmed the causal relationship between insomnia, eight immune cell phenotypes, and eleven metabolite levels. Notably, we found a relationship between leucine-mediated CD4/CD8br and insomnia, providing evidence supporting the causal relationship between immune cell and insomnia, with plasma metabolites serving as mediators.
Keywords: Genetic information; Immunity; Insomnia; Mendelian randomization; Metabolite.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests. Ethical Approval and Consent to Participate: Not applicable. Consent for publication: Not applicable.
Figures






Similar articles
-
Genetically predicted N-methylhydroxyproline levels mediate the association between naive CD8+ T cells and allergic rhinitis: a mediation Mendelian randomization study.Front Immunol. 2024 May 23;15:1396246. doi: 10.3389/fimmu.2024.1396246. eCollection 2024. Front Immunol. 2024. PMID: 38846949 Free PMC article.
-
Causal role of immune cells in Hashimoto's thyroiditis: Mendelian randomization study.Front Endocrinol (Lausanne). 2024 May 13;15:1352616. doi: 10.3389/fendo.2024.1352616. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38803479 Free PMC article.
-
Exploring risk factors for autoimmune diseases complicated by non-hodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study.Front Immunol. 2024 May 28;15:1374938. doi: 10.3389/fimmu.2024.1374938. eCollection 2024. Front Immunol. 2024. PMID: 38863695 Free PMC article.
-
Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization.Front Immunol. 2024 Jun 12;15:1402113. doi: 10.3389/fimmu.2024.1402113. eCollection 2024. Front Immunol. 2024. PMID: 38933268 Free PMC article.
-
Causality of immune cells and endometriosis: a bidirectional mendelian randomization study.BMC Womens Health. 2024 Oct 26;24(1):574. doi: 10.1186/s12905-024-03417-0. BMC Womens Health. 2024. PMID: 39462363 Free PMC article.
Cited by
-
EP300 Regulates CD8br AC (TBNK Panel) to Facilitate Insomnia.Mol Neurobiol. 2025 Jul 9. doi: 10.1007/s12035-025-05188-7. Online ahead of print. Mol Neurobiol. 2025. PMID: 40629249
References
-
- Agrawal S, Singh V, Singh C, Singh A (2022) A review on pathophysiological aspects of sleep deprivation. CNS Neurol Disord Drug Targets. 10.2174/1871527321666220512092718 - PubMed
-
- Akkaoui MA, Palagini L, Geoffroy PA (2023) Sleep immune cross talk and insomnia. Adv Exp Med Biol 1411:263–273. 10.1007/978-981-19-7376-5_12 - PubMed
-
- Biard K, Douglass AB, De Koninck J (2015) The effects of galantamine and buspirone on sleep structure: Implications for understanding sleep abnormalities in major depression. J Psychopharmacol 29(10):1106–1111. 10.1177/0269881115598413 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials